Javascript must be enabled to continue!
Animal Model of Severe Fever With Thrombocytopenia Syndrome Virus Infection
View through CrossRef
Severe fever with thrombocytopenia syndrome (SFTS), an emerging life-threatening infectious disease caused by SFTS bunyavirus (SFTSV; genus Bandavirus, family Phenuiviridae, order Bunyavirales), has been a significant medical problem. Currently, there are no licensed vaccines or specific therapeutic agents available and the viral pathogenesis remains largely unclear. Developing appropriate animal models capable of recapitulating SFTSV infection in humans is crucial for both the study of the viral pathogenic processes and the development of treatment and prevention strategies. Here, we review the current progress in animal models for SFTSV infection by summarizing susceptibility of various potential animal models to SFTSV challenge and the clinical manifestations and histopathological changes in these models. Together with exemplification of studies on SFTSV molecular mechanisms, vaccine candidates, and antiviral drugs, in which animal infection models are utilized, the strengths and limitations of the existing SFTSV animal models and some important directions for future research are also discussed. Further exploration and optimization of SFTSV animal models and the corresponding experimental methods will be undoubtedly valuable for elucidating the viral infection and pathogenesis and evaluating vaccines and antiviral therapies.
Frontiers Media SA
Title: Animal Model of Severe Fever With Thrombocytopenia Syndrome Virus Infection
Description:
Severe fever with thrombocytopenia syndrome (SFTS), an emerging life-threatening infectious disease caused by SFTS bunyavirus (SFTSV; genus Bandavirus, family Phenuiviridae, order Bunyavirales), has been a significant medical problem.
Currently, there are no licensed vaccines or specific therapeutic agents available and the viral pathogenesis remains largely unclear.
Developing appropriate animal models capable of recapitulating SFTSV infection in humans is crucial for both the study of the viral pathogenic processes and the development of treatment and prevention strategies.
Here, we review the current progress in animal models for SFTSV infection by summarizing susceptibility of various potential animal models to SFTSV challenge and the clinical manifestations and histopathological changes in these models.
Together with exemplification of studies on SFTSV molecular mechanisms, vaccine candidates, and antiviral drugs, in which animal infection models are utilized, the strengths and limitations of the existing SFTSV animal models and some important directions for future research are also discussed.
Further exploration and optimization of SFTSV animal models and the corresponding experimental methods will be undoubtedly valuable for elucidating the viral infection and pathogenesis and evaluating vaccines and antiviral therapies.
Related Results
Tracing Hematological Shifts in Pregnancy: How Anemia and Thrombocytopenia Evolve Across Trimesters
Tracing Hematological Shifts in Pregnancy: How Anemia and Thrombocytopenia Evolve Across Trimesters
Abstract
Introduction
Given pregnancy's significant impact on hematological parameters, monitoring these changes across trimesters is crucial. This study aims to evaluate hematolog...
Three in One: Systemic Lupus Erythematosus, HELLP Syndrome, and Antiphospholipid Syndrome: A Case Report and Literature Review
Three in One: Systemic Lupus Erythematosus, HELLP Syndrome, and Antiphospholipid Syndrome: A Case Report and Literature Review
Abstract
Introduction
Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease commonly affecting women of reproductive age. Its overlap with HELLP syndrome (Hemolysi...
Bleeding in neonates with severe thrombocytopenia: a retrospective cohort study
Bleeding in neonates with severe thrombocytopenia: a retrospective cohort study
Abstract
Background
Severe neonatal thrombocytopenia is a rare disease with multiple etiologies. Severe thrombocytopenia with bleeding is life-threa...
Thrombocytopenia in post Covid era: puzzle in the diagnosis.
Thrombocytopenia in post Covid era: puzzle in the diagnosis.
World Health Organization declared the outbreak of coronavirus disease 2019 (COVID-19) a pandemic on March 11, 2020, researchers and clinicians have worked diligently to learn ever...
Frequency of Thrombocytopenia in Malaria and its prognostic significance
Frequency of Thrombocytopenia in Malaria and its prognostic significance
BACKGROUND & OBJECTIVE: Thrombocytopenia is a common hematological manifestation of malaria, but locally there is limited data on the association of thrombocytopenia degree and...
Aetiology of fever in patients with acute stroke *
Aetiology of fever in patients with acute stroke *
Georgilis K, Plomaritoglou A, Dafni U, Bassiakos Y, Vemmos K (University of Athens School of Medicine, ‘Alexandra’ Hospital, Athens, Greece; Harvard School of Public Health, Boston...
Immature platelet fraction as a useful predictor of the aetiology of thrombocytopenia: experience from Oman
Immature platelet fraction as a useful predictor of the aetiology of thrombocytopenia: experience from Oman
Abstract
Clinical evaluation of the possible aetiology of thrombocytopenia is important in the management of thrombocytopenia, which is concomitant with different disease...

